The great advances which have been made in recent years in the treatment of gonorrhea infections would appear to have provided the medical profession with adequate therapeutic agents for this disease. The numerous advantages of penicillin treatment have resulted in its replacing the sulfonamide drugs, except in selected cases (1). Even the disadvantages of parenteral injections of penicillin have been avoided by a number of workers who have administered the antibiotic by mouth (1). Indeed, Campbell, Dougherty and Curtis reported on the oral use of penicillin in the prophylaxis of gonorrhea at an earlier session of this Symposium (2) . Despite the fact that penicillin has many attributes of an ideal drug for the treatment of gonorrhea, it has one distinct drawback, i.e., its suppressive effect on a coexisting syphilitic infection. This problem of the possible masking of syphilis by treating acute gonorrhea patients with-amounts of penicillin which are adequate for the bacterial infection but inadequate for the spirochetal infection is of tremendous importance (1, 3). Therefore, the search must continue for a drug with the activity of penicillin against the gonococcus but without its marked anti-spirochetal action. This report is a progress note which presents certain preliminary data suggesting that chloramphenicol, or Chloromycetin,2 approaches penicillin in its efficacy in the treatment of acute gonorrheal urethritis in the male and that this new drug is distinctly less spirocheticidal than penicillin. Table I . Each person had a purulent urethral discharge when admitted to the study. This had been present for three days or less in the majority of instances, but three individuals in the group had suffered for 21, 28, and 60 days, respectively. The mean duration of disease when therapy was begun was from four to 12 days in the four subgroups listed in Table I . Smears of the exudate taken from each patient Within 24 hours after the therapeutic dose had been given the urethral discharge had disappeared in 13 of the 32 patients. Furthermore, in another 17 of the group the discharge was reduced to a drop or so of thin watery material which was obtained by stripping. Two of the 32 persons still yielded a drop of purulent exudate at this time. Stained smears of the 19 exudates revealed that only one had Gram-negative intracellular diplococci; the culture of this material failed to yield N. gonococci. However, a few colonies of N. gonococci were grown from a thin milky exudate of another patient who was cultured 24 hours after being given 3.0 grams of drug. Furthermore, the material from three other patients taken at this time yielded colonies resembling N. gonococci.
On the third to fifth days after treatment was given, 30 of the 32 patients were subjected to prostatic massage. Materials for smear and culture were obtained from 18 of these. In no instance were Gram-negative intracellular diplococci found microscopically; indeed, even leukocytes were recorded as being absent from the smears of 12 of the specimens. Seventeen of the 18 cultures of prostatic secretion taken during this period contained no N. gonococci but from one secretion a few colonies were grown which resembled gonococci morphologically. Three subsequent massages of Patient Three additional patients not included in the table are worthy of mention. Each received a single dose of 1.0 or 1.5 grams of Chloromycetin but was subsequently given an additional 3.0-gram dose one to four days later. This additional medication appeared indicated because of the persistence of some discharge, or the presence of Gram-negative intracellular diplococci. However, none of the cultures taken at the time the supplementary drug was administered were later found to contain gonococci. Each of the three patients recovered promptly after being given the additional drug. Thus, it appears that the administration of 1.0 gram or 1.5 grams of drug in a single dose may provide inadequate therapy in a proportion of cases.
Smith and his coworkers (4) found that rabbits which had been infected with the Nichols strain of Treponema pallidum and then treated with Chloromycetin for eight days at the rate of 25 mg. per kilo per day showed no change in their lesions nor did the spirochetes disappear. They also noted that daily doses of 50 and 100 mg. per kilo cleared the lesions of spirochetes but that the effect was temporary.
Our experience with Chloromycetin in two patients with primary chancres suggests that the results in man may be similar to those just mentioned in rabbits. Dark field examination of fluid from the lesion of one man showed an average of three motile spirochetes per field. The patient received 4.0 grams of Chloromycetin in a single dose (45 mg. per kilo of body weight) and repeated examinations over the next 18 hours revealed the same number of active treponema. He was then given 3.0 grams of drug at one time followed by five doses of 0. (5) . This may be due to our use of larger amounts of drug. The mean duration of disease before treatment in this series was 15 days. Dysuria and discharge disappeared on the average in 29 and 82 hours, respectively. In all cases smears were negative for gonococci by the day after treatment. These patients were followed for-an average of 28 days during which time there were no relapses. 
